Quest Diagnostics
Submit RFI/RFPQuest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 44,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
Visit http://www.questdiagnostics.com/home/about for more information.
Contact Address | Edificio Federal Frente al Hospital Hermanos Melendez, Bayamon PR 00960 US |
Phone Number | 787-787-7577 |
NA | |
Website | http://www.questdiagnostics.com/home.html |
Category | Value Based Care |
Products & Solutions
Products & Solutions | Diagnostic Testing and Services, Clinical Testing, Cancer Diagnostics and Anatomic Pathology Services, Gene-based and other Esoteric Testing, Healthcare Technology Solutions. |
Services
Services | Diagnostic Testing Services, Healthcare IT, Wellness and Risk Management, Clinical Trials Testing |
Key Executives
![]() |
Stephen H. Rusckowski President and Chief Executive Officer
Since joining Quest Diagnostics in May 2012, Mr. Rusckowski has focused on transforming the company, based on its compelling vision of Empowering better health with diagnostic insights. Under his leadership, the company has refocused on its core diagnostic information services business, sold non-core assets, delivered disciplined deployment, including share repurchases and acquisitions, and simplified its organizational structure to better serve customers by removing complexity, speeding decision making and empowering employees. Prior to joining Quest Diagnostics, Mr. Rusckowski was CEO of Philips Healthcare, which became the largest unit of Royal Philips Electronics under his leadership. |
![]() |
Jay G. Wohlgemuth, M.D., is Chief Medical Officer and Senior Vice President, Research & Development and Medical for Quest Diagnostics.
Based at Quest Diagnostics Nichols Institute, in San Juan Capistrano, California, Dr. Wohlgemuth is responsible for Research & Development (R&D), Medical Affairs, and Medical/Lab Quality. In addition, he is responsible for improving outcomes for employees who use our health benefits. Dr. Wohlgemuth has many years of experience in medical diagnostics and research and development. He rejoined Quest in 2016 from HealthTap, a health information start-up, where he served as Senior Vice President and Chief Healthcare Officer. |
White Papers & Resources
Resources | Drug Testing Resource, Industry Expert Resources |
More Like This

For more than 125 years, Carstens has focused on the specific and evolving needs of healthcare profe...

RxAdvance’s pharmacy benefit management service offers a proven and innovative solution. We drive ...
SHPS, Inc. provides health management services in the United States. Its services include care manag...

eviti, Inc. is a leading health information technology and clinical decision-support company deliver...

Intelligent InSites helps healthcare organizations reduce costs and improve care by transforming aut...

Aprexis, our mission is to create a solution for effectively navigating medication therapy managemen...

Optum is a health services and innovation company dedicated to helping make the health system work b...

Wellframe partners with leading health plans and healthcare providers to deliver a mobile-enabled ca...

Pharmacy Quality Solutions, Inc. (PQS) is a joint venture created to fill the need to connect medica...

Client Outlook is an innovative healthcare technology company that designs imaging solutions which p...

SelfHelpWorks partners with employers, wellness vendors, health plans and medical providers to deliv...

LifeAssist is passionate about simplifying the lives of caregivers, providers and seniors. Our prod...

CoverMyMeds was founded in 2008 with a mission to automate the medication prior authorization (PA) p...